A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies.
Clin Cancer Res
; 15(8): 2935-41, 2009 Apr 15.
Article
in En
| MEDLINE
| ID: mdl-19351765
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organometallic Compounds
/
Carcinoembryonic Antigen
/
Deoxycytidine
/
Gastrointestinal Neoplasms
/
Antibodies, Monoclonal
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2009
Type:
Article
Affiliation country:
United States